Similar articles

• [Non-A, non-B hepatitis-related antigens and antibodies and experimental infection].

  Yoshizawa H. Yoshizawa H. Rinsho Byori. 1984 Nov;32(11):1202-12. Rinsho Byori. 1984. PMID: 6084080 Review. Japanese. No abstract available.
• [Clinical aspects and risk factors in posttransfusion hepatitis].

  Realdi G, Tremolada F, Chiappetta F, Antona C, Noventa F, Loreggian M, Chemello L, Alberti A. Realdi G, et al. Ric Clin Lab. 1984;14 Suppl 1:17-35. Ric Clin Lab. 1984. PMID: 6330858 Review. Italian. No abstract available.
• [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].

  Bedarida G, Cambiè G, D'Agostino F, Sterza G. Bedarida G, et al. Ric Clin Lab. 1984;14 Suppl 1:37-60. Ric Clin Lab. 1984. PMID: 6429830 Review. Italian. No abstract available.
• Viral markers of hepatitis.

  Velasco M. Velasco M. Lab Res Methods Biol Med. 1983;7:103-17. Lab Res Methods Biol Med. 1983. PMID: 6413796 Review. No abstract available.
• Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis.

  Koretz RL, Brezina M, Polito AJ, Quan S, Wilber J, Dinello R, Gitnick G. Koretz RL, et al. Hepatology. 1993 Mar;17(3):361-5. Hepatology. 1993. PMID: 8383087